The Rare2030 Foresight Study continues! After one year of reflection and with a nearly 200-person-strong Panel of Experts, the study has reached its third phase.
Led by EURORDIS with nine project partners and initiated with the support of the European Commission and European Parliament, the Rare2030 Foresight Study is laying the foundations for policies that will create a better future for people living with a rare disease in Europe. Watch the new Rare2030 scenarios video.
|EUROPEAN CONFERENCE ON RARE DISEASES & ORPHAN PRODUCTS|
|EURORDIS BLACK PEARL AWARDS|
|RARE BAROMETER VOICES|
|WHAT'S NEW AT EURORDIS?|
|PATIENTS ADVANCING RESEARCH|
This publication (or activity) has been funded with support from the European Union's Health Programme. This material only reflects the views of the author, and funders cannot be held responsible for any use which may be made of the information contained herein.